The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device
The Journal of Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1016/j.jtcvs.2024.09.028 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Taylor Nordan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Hauptthemen laut MEDLINE: Heart-Assist Devices, Intra-Aortic Balloon Pumping, Heart Transplantation, Waiting Lists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Waitlist time for United Network for Organ Sharing Status 2 heart transplant candidates has steadily increased. We compared a bridging strategy using either the Impella 5.0/5.5 ("Impella") or intra-aortic balloon pump with a durable left ventricular assist device in patients with blood type O stratified by body habitus. METHODS: The United Network for Organ Sharing registry was queried for adults listed for de novo heart transplantation (without dialysis) supported by the Impella, an intra-aortic balloon pump, or the HeartMate 3 left ventricular assist device. The primary outcome was 1-year postlisting survival, defined as the sum of waitlist time and post-heart transplant survival time if the candidate underwent heart transplantation. RESULTS: In total, 2942 candidates were included (Impella: 214; intra-aortic balloon pump: 1326; HeartMate 3: 1402). Listing with the Impella or intra-aortic balloon pump was associated with worse postlisting survival compared with the HeartMate 3 left ventricular assist device in type O candidates (Impella: hazard ratio, 2.90 [95% CI, 1.48-5.67], P = .002; intra-aortic balloon pump: hazard ratio, 2.42 [95% CI, 1.59-3.68], P < .001) but less so in non-type O candidates. Further analysis of type O candidates demonstrated that the Impella and intra-aortic balloon pump were associated with a lower risk of postlisting mortality among those with normal height (25-75th percentile) and nonobese (body mass index
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
- Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
- Division of Cardiac Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Electronic address: aitoh@bwh.harvard.edu.
Zitieren
APA
Nordan, T., Keshk, M., Hackmann, A., Givertz, M. M., Mehra, M. R., Cunningham, M. J., & Itoh, A. (2025). The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.09.028
Vancouver
Nordan T, Keshk M, Hackmann A, Givertz MM, Mehra MR, Cunningham MJ, et al. The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.09.028
BibTeX
@article{Nordan2025,
author = {Nordan, Taylor and Keshk, Mohamed and Hackmann, Amy and Givertz, Michael M and Mehra, Mandeep R and Cunningham, Mark J and Itoh, Akinobu},
title = {The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1016/j.jtcvs.2024.09.028}
}
EUVIMED